List of Studies ( Metabolite:SM 18:0;O2/20:0)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST003751 | AN006158 | Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome | Blood | Human | Kidney disease | Universidad CEU San Pablo | LC-MS |
| ST003751 | AN006158 | Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome | Urine | Human | Kidney disease | Universidad CEU San Pablo | LC-MS |
| ST003751 | AN006159 | Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome | Blood | Human | Kidney disease | Universidad CEU San Pablo | LC-MS |
| ST003751 | AN006159 | Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome | Urine | Human | Kidney disease | Universidad CEU San Pablo | LC-MS |
| ST003672 | AN006029 | Advanced Lipidomics Using UHPLC-ESI-QTOF-MS/MS Reveals Novel Lipids in Hibernating Syrian Hamsters | Brain | Golden hamster | Universidad CEU San Pablo | LC-MS | |
| ST003514 | AN005769 | Highly reliable LC-MS lipidomics database for efficient human plasma profiling based on NIST SRM 1950 | Blood | Human | Universidad CEU San Pablo | LC-MS | |
| ST003326 | AN005449 | Lipidome profiling in non-alcoholic steatohepatitis identifies phosphatidylserine synthase 1 as a regulator of hepatic lipoprotein metabolism | Liver | Mouse | Liver disease | University of Melbourne | LC-MS |
| ST003222 | AN005283 | A small molecule macrophage migration inhibitory factor agonist ameliorates age-related myocardial intolerance to ischemia-reperfusion insults via metabolic regulation - Part 1 | Heart | Mouse | Ischemia | University of Mississippi Medical Center | LC-MS |
| ST003220 | AN005280 | Obesity, sex, and depot drive distinct lipid profiles in murine white adipose tissue | Adipose tissue | Mouse | Obesity | University of Utah | LC-MS |
| ST003215 | AN005272 | Protein restriction slows the development and progression of Alzheimer's disease in mice | Brain | Mouse | Alzheimers disease | University of Wisconsin-Madison | LC-MS |
| ST003103 | AN005077 | Reinforcing the Evidence of Mitochondrial Dysfunction in Long COVID Patients using a Multiplatform Mass Spectrometry-based Metabolomics Approach | Blood | Human | COVID-19 | Universidad CEU San Pablo | GC-MS/LC-MS |
| ST003044 | AN004994 | A High-Fat Eucaloric Diet Induces Reprometabolic Syndrome of Obesity in Normal Weight Women - lipidomics | Blood | Human | Obesity | University of Colorado Denver | LC-MS |
| ST003038 | AN004985 | Untargeted lipidomics of WT and Cyp2c44(-/-) mice liver. | Liver | Mouse | Diabetes | Vanderbilt University Medical Center | LC-MS |
| ST002956 | AN004853 | An application of automated LLE extraction in determine the age and HFD effects in adult mice in metabolomic, lipidomic, and proteomic | Blood | Mouse | Calico Life Sciences | LC-MS | |
| ST002911 | AN004780 | LiLA: Lipid Lung-based ATLAS built Through a Comprehensive Workflow Designed for an Accurate Lipid Annotation | Lung | Mouse | Tuberculosis | Universidad CEU San Pablo | LC-MS |
| ST002911 | AN004781 | LiLA: Lipid Lung-based ATLAS built Through a Comprehensive Workflow Designed for an Accurate Lipid Annotation | Lung | Mouse | Tuberculosis | Universidad CEU San Pablo | LC-MS |
| ST002787 | AN004534 | Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome | Feces | Human | Cancer | Wuhan University of Science and Technology | LC-MS |
| ST001942 | AN003184 | Lipidomics of esophageal adenocarcinoma | Esophagus | Human | Cancer | QIMR Berghofer Medical Research Institute | LC-MS |
| ST001819 | AN002952 | EC and PVC from 14-15 month-old APOE3/3, APOE3/4 and APOE4/4 mice | Brain | Mouse | Alzheimers disease | Columbia University | LC-MS |
| ST001336 | AN002226 | Effect of high-fat diet and bile acid treatment on serum and tissue lipidomes in mice | Blood | Mouse | QIMR Berghofer Medical Research Institute | LC-MS | |
| ST001323 | AN002199 | Effect of high-fat diet on serum lipidome in mice | Blood | Mouse | QIMR Berghofer Medical Research Institute | LC-MS | |
| ST001289 | AN002142 | Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses | Macrophages | Mouse | LIPID MAPS | GC-MS/LC-MS | |
| ST001288 | AN002141 | Subcellular organelle lipidomics in TLR-4-activated macrophages | Macrophages | Mouse | LIPID MAPS | LC-MS | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST000917 | AN001501 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 3:Urine | Urine | Human | Fatty liver disease | LIPID MAPS | GC-MS/LC-MS |
| ST000916 | AN001495 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma | Blood | Human | Fatty liver disease | LIPID MAPS | GC-MS/LC-MS |
| ST000915 | AN001489 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver | Liver | Human | Fatty liver disease | LIPID MAPS | GC-MS/LC-MS |
| ST000620 | AN000952 | Sphingolipid Analysis of hyper and normotensive DBA2J mice aqueous humor and trabecular meshwork | Eye tissue | Mouse | Eye disease | University of Miami | MS(Dir. Inf.) |
| ST000613 | AN000938 | Human TM Sphingolipid Analysis (part II) | Eye tissue | Human | Eye disease | University of Miami | MS(Dir. Inf.) |
| ST000612 | AN000937 | Sphingolipid Analysis of Human Aqueous Humor in Glaucomatous and Control eyes | Eye tissue | Human | Eye disease | University of Miami | MS(Dir. Inf.) |
| ST000422 | AN000669 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000005 | AN000012 | Timecourse on RAW 264.7 cells treated with Kdo2-Lipid A and compactin | Macrophages | Mouse | LIPID MAPS | GC-MS/LC-MS |
